These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2508064)

  • 61. Independent immunoglobulin class-switch events occurring in a single myeloma cell line.
    Eckhardt LA; Birshtein BK
    Mol Cell Biol; 1985 Apr; 5(4):856-68. PubMed ID: 3921826
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Activator proteins which regulate immunoglobulin heavy chain gene transcription in B lymphocytes.
    Roman C; Riggs K; Merrell K; Calame K
    Prog Clin Biol Res; 1990; 352():241-8. PubMed ID: 2119507
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locus.
    Dyer MJ; Lillington DM; Bastard C; Tilly H; Lens D; Heward JM; Stranks G; Morilla R; Monrad S; Guglielmi P; Kluin-Nelemans JC; Hagemeijer A; Young BD; Catovsky D
    Leukemia; 1996 Jul; 10(7):1198-208. PubMed ID: 8684002
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The "missing" mouse plasmacytoma (MPC) associated translocation T(15;16) occurs repeatedly in new MPC induction systems.
    Wiener F; Silva S; Sugiyama H; Babonits M; Klein G
    Genes Chromosomes Cancer; 1990 May; 2(1):36-43. PubMed ID: 2126192
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas.
    Martín-Subero JI; Odero MD; Hernandez R; Cigudosa JC; Agirre X; Saez B; Sanz-García E; Ardanaz MT; Novo FJ; Gascoyne RD; Calasanz MJ; Siebert R
    Genes Chromosomes Cancer; 2005 Aug; 43(4):414-23. PubMed ID: 15852472
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Frequent detection of bcl-2/JH translocations in human blood and organ samples by a quantitative polymerase chain reaction assay.
    Ji W; Qu GZ; Ye P; Zhang XY; Halabi S; Ehrlich M
    Cancer Res; 1995 Jul; 55(13):2876-82. PubMed ID: 7796416
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Utility of a rapid polymerase chain reaction panel for the detection of molecular changes in B-cell lymphoma.
    Abdel-Reheim FA; Edwards E; Arber DA
    Arch Pathol Lab Med; 1996 Apr; 120(4):357-63. PubMed ID: 8619747
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fusion of DNA region to murine immunoglobulin heavy chain locus corresponds to plasmacytoma-associated chromosome translocation.
    Cory S; Adams JM; Gerondakis SD; Miller JF; Gamble J; Wiener F; Spira J; Francke U
    EMBO J; 1983; 2(2):213-6. PubMed ID: 11894928
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Constitutive activation of oncogenes by chromosomal translocations in B-cell derived tumors.
    Klein G
    AIDS Res; 1986 Dec; 2 Suppl 1():S167-76. PubMed ID: 3030345
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Isotype switch-mediated CH deletions are a recurrent feature of Myc/CH translocations in peritoneal plasmacytomas in mice.
    Kovalchuk AL; Janz S
    Int J Cancer; 2002 Oct; 101(5):423-6. PubMed ID: 12216069
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas.
    Bhatia K; Huppi K; Spangler G; Siwarski D; Iyer R; Magrath I
    Nat Genet; 1993 Sep; 5(1):56-61. PubMed ID: 8220424
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Detection of immunoglobulin/c-myc recombinations in mice that are resistant to plasmacytoma induction.
    Müller JR; Jones GM; Potter M; Janz S
    Cancer Res; 1996 Jan; 56(2):419-23. PubMed ID: 8542601
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line.
    Bemark M; Neuberger MS
    Oncogene; 2000 Jul; 19(30):3404-10. PubMed ID: 10918597
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Plasmacytoma with crystal-storing histiocytosis exhibiting FGFR3 and IgH translocation.
    Lv Y; Liu Y; Li X; Yan Q; Wang Z
    Pathology; 2015 Jan; 47(1):82-5. PubMed ID: 25474517
    [No Abstract]   [Full Text] [Related]  

  • 75. [Chromosome translocations and the activation of C-myc oncogene in mouse plasmacytomas].
    Ohno S
    Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):587-96. PubMed ID: 6424577
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The IgH 3' regulatory region and c-myc-induced B-cell lymphomagenesis.
    Ghazzaui N; Saintamand A; Issaoui H; Vincent-Fabert C; Denizot Y
    Oncotarget; 2017 Jan; 8(4):7059-7067. PubMed ID: 27729620
    [TBL] [Abstract][Full Text] [Related]  

  • 77. DNA sequences involved in the rearrangement and expression of the murine c-myc gene.
    Dunnick W; Baumgartner J; Fradkin L; Schultz C
    Curr Top Microbiol Immunol; 1984; 113():154-60. PubMed ID: 6478863
    [No Abstract]   [Full Text] [Related]  

  • 78. Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the E mu enhancer.
    Cutrona G; Carpaneto EM; Ponzanelli A; Ulivi M; Millo E; Scarfì S; Roncella S; Benatti U; Boffa LC; Ferrarini M
    Cancer Res; 2003 Oct; 63(19):6144-8. PubMed ID: 14559793
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Direct evidence for intrastrand DNA inversion of kappa immunoglobulin gene segments in two murine plasmacytomas.
    Feddersen R; Van Ness B
    Nucleic Acids Res; 1989 Dec; 17(23):9797-809. PubMed ID: 2513557
    [TBL] [Abstract][Full Text] [Related]  

  • 80. B-cell tumorigenesis in mice carrying a yeast artificial chromosome-based immunoglobulin heavy/c-myc translocus is independent of the heavy chain intron enhancer (Emu).
    Palomo C; Zou X; Nicholson IC; Bützler C; Brüggemann M
    Cancer Res; 1999 Nov; 59(21):5625-8. PubMed ID: 10554044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.